Vericel (VCEL) delivered earnings and revenue surprises of +75.00% and -1.33%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

An innovative new study from researchers at the Center for Healthy Brain Aging (CHeBA), UNSW Sydney, reveals that something as simple as a mouse's dinner could be distorting critical preclinical ...